Waldenström Macroglobulinemia
📧 Sign up to get email alerts when something new happens for Waldenström Macroglobulinemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a two-step reduced-intensity conditioning approach for bone marrow transplant in adults with hematologic malignanci…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies [Phase 1]
NX-5948 is being studied in a Phase 1 trial for adults with relapsed/refractory B-cell malignancies; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: SynKIR-310 for Relapsed/Refractory B-NHL [Phase 1]
Phase 1 trial update for SynKIR-310 in relapsed/refractory B-cell non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T [Phase 1]
This clinical trial update reports long-term follow-up results from a Phase 1 study of CLBR001 CAR-T cells in relapsed/refractory B-cell lym…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of lenalidomide with DA-EPOCH-R in MYC-associated B-cell lymphomas has completed, and results hav…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies [Phase 2]
Phase 2 trial of Brexucabtagene Autoleucel in adults with rare B-cell malignancies has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating ixazomib citrate with rituximab in indolent B-cell non-Hodgkin lymphoma has posted results.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia [Phase 4]
Phase 4 clinical trial comparing RCD versus BCD regimens in newly diagnosed Waldenström macroglobulinemia has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM [Phase 4]
A Phase 4 trial assessing the efficacy of a TCD regimen followed by TP maintenance in newly diagnosed Waldenström macroglobulinemia has comp…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia [Phase 2]
A Phase 2 clinical trial evaluating the combination of zanubrutinib, ixazomib, and dexamethasone in treatment-naive Waldenström macroglobuli…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia [Phase 4]
A Phase 4 clinical trial comparing autologous stem cell transplantation to conventional chemotherapy in high-risk Waldenström macroglobuline…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 clinical trial evaluating bendamustine, rituximab, and acalabrutinib in Waldenström macroglobulinemia is currently active and not re…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment [Phase 2]
This update summarizes a Phase 2 trial of zanubrutinib (BGB-3111) in participants with previously treated B-cell lymphomas intolerant to pri…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial of the oral BTK inhibitor LOXO-305 (pirtobrutinib) in patients with previously treated chronic lymphocy…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Detection of Recurrent Mutations in Waldenström's Disease [NA]
A completed clinical trial investigated recurrent mutations in Waldenström macroglobulinemia.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy of the first-line B-RI regimen in treatment-naive Waldenström's macroglobulinemia.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma [Phase 1, Phase 2]
Clinical trial update describing a multicenter, single-arm Phase I/II exploratory study to assess the safety and efficacy of a fully human B…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Completed clinical trial update examining how patients with multiple myeloma and Waldenström macroglobulinemia respond to COVID-19 vaccinati…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS
The study evaluating non-invasive diagnostics and monitoring of minimal residual disease and clonal evolution in Waldenström macroglobulinem…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia [Phase 2]
Phase 2 study evaluating a combination of ibrutinib and ixazomib citrate in newly diagnosed, relapsed, or refractory Waldenström macroglobul…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) [Phase 1]
Phase I clinical trial update for BR101801 in adults with advanced hematologic malignancies; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia [Phase 1]
This update reports results from a Phase 1 trial evaluating pomalidomide in patients with relapsed or refractory Waldenström macroglobulinem…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers [Phase 1]
This is a Phase 1 clinical trial update for a CAR T cell therapy (19(T2)28z1xx) in various B-cell cancers. The study is sponsored by Memoria…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia [Phase 1]
A Phase 1 trial evaluating APG-2575 as a single agent or in combination with ibrutinib or rituximab in Waldenström macroglobulinemia has com…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM) [Phase 4]
Phase 4 study of ibrutinib in Chinese participants with relapsed or refractory Waldenström macroglobulinemia has been completed and results …